Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Tract Infections 2Urinary Bladder Neoplasms 1Rectal Neoplasms 1Diverticulosis, Colonic 1Colonic Neoplasms 1

Interventions

Trimethoprim, Sulfamethoxazole Drug Combination 2Fosfomycin 2Ertapenem 2Ciprofloxacin 2Amikacin 2ziprasidone 1Zolpidem 1Warfarin 1Vecuronium Bromide 1Vancomycin 1Tranexamic Acid 1Tobramycin 1Spironolactone 1Sevelamer 1Rocuronium 1Replens 1Povidone-Iodine 1Piperacillin, Tazobactam Drug Combination 1Pentobarbital 1Oxycodone 1Optical Imaging 1Ofloxacin 1OM 89 1Nitrofurantoin 1Nifedipine 1Nafcillin 1Molindone 1Methylprednisolone 1Lurasidone Hydrochloride 1Levofloxacin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Urinary Tract Infections × Ertapenem × Clear all
NCT04502095 2025-08-03

Prophylactic Antibiotics for Urinary Tract Infections After Robot-Assisted Radical Cystectomy

Roswell Park Cancer Institute

Phase 4 Completed
89 enrolled
Genitourinary

Urinary Bladder Neoplasms, Urinary Tract Infections

NCT03218800 2022-08-11

Ertapenem Administered Subcutaneously Versus Intravenously

Instituto Nacional de Cancer, Brazil

Phase 3 Terminated
30 enrolled

Urinary Tract Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡